請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/69972
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 潘建源(Chien-Yuen Pan) | |
dc.contributor.author | Ming-Yi Chou | en |
dc.contributor.author | 周明毅 | zh_TW |
dc.date.accessioned | 2021-06-17T03:36:44Z | - |
dc.date.available | 2020-03-02 | |
dc.date.copyright | 2018-03-02 | |
dc.date.issued | 2017 | |
dc.date.submitted | 2018-02-11 | |
dc.identifier.citation | Abe, T., Seo, T., Ishitsu, T., Nakagawa, T., Hori, M. and Nakagawa, K., (2008). Association between SCN1A polymorphism and carbamazepine-resistant epilepsy. Br J Clin Pharmacol 66(2): 304-307.
Abriel, H. and Kass, R. S., (2005). Regulation of the voltage-gated cardiac sodium channel Nav1.5 by interacting proteins. Trends Cardiovasc Med 15(1): 35-40. Adachi, N., Tomonaga, S., Tachibana, T., Denbow, D. M. and Furuse, M., (2006). (-)-Epigallocatechin gallate attenuates acute stress responses through GABAergic system in the brain. Eur J Pharmacol 531(1-3): 171-175. Andrade, J. P. and Assuncao, M., (2012). Protective effects of chronic green tea consumption on age-related neurodegeneration. Curr Pharm Des 18(1): 4-14. Andrasfalvy, B. K. and Mody, I., (2006). Differences between the scaling of miniature IPSCs and EPSCs recorded in the dendrites of CA1 mouse pyramidal neurons. J Physiol 576(Pt 1): 191-196. Bae, J. H., Mun, K. C., Park, W. K., Lee, S. R., Suh, S. I., Baek, W. K., Yim, M. B., Kwon, T. K. and Song, D. K., (2002). EGCG attenuates AMPA-induced intracellular calcium increase in hippocampal neurons. Biochem Biophys Res Commun 290(5): 1506-1512. Beckh, S., Noda, M., Lubbert, H. and Numa, S., (1989). Differential regulation of three sodium channel messenger RNAs in the rat central nervous system during development. Embo j 8(12): 3611-3616. Bell, T. J., Thaler, C., Castiglioni, A. J., Helton, T. D. and Lipscombe, D., (2004). Cell-specific alternative splicing increases calcium channel current density in the pain pathway. Neuron 41(1): 127-138. Berg, A. T., Berkovic, S. F., Brodie, M. J., Buchhalter, J., Cross, J. H., van Emde Boas, W., Engel, J., French, J., Glauser, T. A., Mathern, G. W., Moshe, S. L., Nordli, D., Plouin, P. and Scheffer, I. E., (2010). Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51(4): 676-685. Berridge, M. J., Lipp, P. and Bootman, M. D., (2000). The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1(1): 11-21. Blencowe, B. J., (2006). Alternative splicing: new insights from global analyses. Cell 126(1): 37-47. Bootman, M. D., Collins, T. J., Peppiatt, C. M., Prothero, L. S., MacKenzie, L., De Smet, P., Travers, M., Tovey, S. C., Seo, J. T., Berridge, M. J., Ciccolini, F. and Lipp, P., (2001). Calcium signalling--an overview. Semin Cell Dev Biol 12(1): 3-10. Bordey, A. and Spencer, D. D., (2004). Distinct electrophysiological alterations in dentate gyrus versus CA1 glial cells from epileptic humans with temporal lobe sclerosis. Epilepsy Res 59(2-3): 107-122. Bouhours, M., Luce, S., Sternberg, D., Willer, J. C., Fontaine, B. and Tabti, N., (2005). A1152D mutation of the Na+ channel causes paramyotonia congenita and emphasizes the role of DIII/S4-S5 linker in fast inactivation. J Physiol 565(Pt 2): 415-427. Brackenbury, W. J. and Djamgoz, M. B., (2006). Activity-dependent regulation of voltage-gated Na+ channel expression in Mat-LyLu rat prostate cancer cell line. J Physiol 573(Pt 2): 343-356. Brodie, M. J. and French, J. A., (2000). Management of epilepsy in adolescents and adults. Lancet 356(9226): 323-329. Calabresi, P., Centonze, D., Marfia, G. A., Pisani, A. and Bernardi, G., (1999). An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons. Br J Pharmacol 126(3): 689-696. Campos-Toimil, M. and Orallo, F., (2007). Effects of (-)-epigallocatechin-3-gallate in Ca2+-permeable non-selective cation channels and voltage-operated Ca2+ channels in vascular smooth muscle cells. Life Sci 80(23): 2147-2153. Carr, D. B., Day, M., Cantrell, A. R., Held, J., Scheuer, T., Catterall, W. A. and Surmeier, D. J., (2003). Transmitter modulation of slow, activity-dependent alterations in sodium channel availability endows neurons with a novel form of cellular plasticity. Neuron 39(5): 793-806. Catterall, W. A., (2012). Voltage-gated sodium channels at 60: structure, function and pathophysiology. J Physiol 590(11): 2577-2589. Catterall, W. A. and Few, A. P., (2008). Calcium channel regulation and presynaptic plasticity. Neuron 59(6): 882-901. Catterall, W. A., Kalume, F. and Oakley, J. C., (2010). NaV1.1 channels and epilepsy. J Physiol 588(Pt 11): 1849-1859. Cestele, S., Yarov-Yarovoy, V., Qu, Y., Sampieri, F., Scheuer, T. and Catterall, W. A., (2006). Structure and function of the voltage sensor of sodium channels probed by a beta-scorpion toxin. J Biol Chem 281(30): 21332-21344. Chanda, B. and Bezanilla, F., (2002). Tracking voltage-dependent conformational changes in skeletal muscle sodium channel during activation. J Gen Physiol 120(5): 629-645. Chater, T. E. and Goda, Y., (2014). The role of AMPA receptors in postsynaptic mechanisms of synaptic plasticity. Front Cell Neurosci 8: 401. Cheah, C. S., Yu, F. H., Westenbroek, R. E., Kalume, F. K., Oakley, J. C., Potter, G. B., Rubenstein, J. L. and Catterall, W. A., (2012). Specific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome. Proc Natl Acad Sci U S A 109(36): 14646-14651. Chen, Q., Guo, Z. and Zhao, J., (2008). Identification of green tea's (Camellia sinensis (L.)) quality level according to measurement of main catechins and caffeine contents by HPLC and support vector classification pattern recognition. J Pharm Biomed Anal 48(5): 1321-1325. Chen, X., Chi, S., Liu, M., Yang, W., Wei, T., Qi, Z. and Yang, F., (2005). Inhibitory effect of ganglioside GD1b on K+ current in hippocampal neurons and its involvement in apoptosis suppression. J Lipid Res 46(12): 2580-2585. Chen, Y., Yu, F. H., Surmeier, D. J., Scheuer, T. and Catterall, W. A., (2006). Neuromodulation of Na+ channel slow inactivation via cAMP-dependent protein kinase and protein kinase C. Neuron 49(3): 409-420. Choquet, D., (2010). Fast AMPAR trafficking for a high-frequency synaptic transmission. Eur J Neurosci 32(2): 250-260. Chow, H. H., Cai, Y., Hakim, I. A., Crowell, J. A., Shahi, F., Brooks, C. A., Dorr, R. T., Hara, Y. and Alberts, D. S., (2003). Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 9(9): 3312-3319. Clay, J. R., (2003). On the persistent sodium current in squid giant axons. J Neurophysiol 89(1): 640-644. Colombo, E., Franceschetti, S., Avanzini, G. and Mantegazza, M., (2013). Phenytoin inhibits the persistent sodium current in neocortical neurons by modifying its inactivation properties. PLoS One 8(1): e55329. Connors, B. W., (1981). A comparison of the effects of pentobarbital and diphenylhydantoin on the GABA sensitivity and excitability of adult sensory ganglion cells. Brain Res 207(2): 357-369. Copley, R. R., (2004). Evolutionary convergence of alternative splicing in ion channels. Trends Genet 20(4): 171-176. Dai, J. and Mumper, R. J., (2010). Plant phenolics: extraction, analysis and their antioxidant and anticancer properties. Molecules 15(10): 7313-7352. Deng, H. M., Yin, S. T., Yan, D., Tang, M. L., Li, C. C., Chen, J. T., Wang, M. and Ruan, D. Y., (2008). Effects of EGCG on voltage-gated sodium channels in primary cultures of rat hippocampal CA1 neurons. Toxicology 252(1-3): 1-8. Dichgans, M., Freilinger, T., Eckstein, G., Babini, E., Lorenz-Depiereux, B., Biskup, S., Ferrari, M. D., Herzog, J., van den Maagdenberg, A. M., Pusch, M. and Strom, T. M., (2005). Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366(9483): 371-377. Diniz, T. C., Silva, J. C., de Lima-Saraiva, S. R., Ribeiro, F. P., Pacheco, A. G., de Freitas, R. M., Quintans-Junior, L. J., Quintans Jde, S., Mendes, R. L. and Almeida, J. R., (2015). The role of flavonoids on oxidative stress in epilepsy. Oxid Med Cell Longev 2015: 171756. Dolly, O., (2003). Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins. Headache 43 Suppl 1: S16-24. Dona, M., Dell'Aica, I., Calabrese, F., Benelli, R., Morini, M., Albini, A. and Garbisa, S., (2003). Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J Immunol 170(8): 4335-4341. Dravet, C., (2011a). The core Dravet syndrome phenotype. Epilepsia 52 Suppl 2: 3-9. Dravet, C., (2011b). Dravet syndrome history. Dev Med Child Neurol 53 Suppl 2: 1-6. Duflocq, A., Le Bras, B., Bullier, E., Couraud, F. and Davenne, M., (2008). Nav1.1 is predominantly expressed in nodes of Ranvier and axon initial segments. Mol Cell Neurosci 39(2): 180-192. Escayg, A. and Goldin, A. L., (2010). Sodium channel SCN1A and epilepsy: mutations and mechanisms. Epilepsia 51(9): 1650-1658. Escayg, A., MacDonald, B. T., Meisler, M. H., Baulac, S., Huberfeld, G., An-Gourfinkel, I., Brice, A., LeGuern, E., Moulard, B., Chaigne, D., Buresi, C. and Malafosse, A., (2000). Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 24(4): 343-345. Feng, W., Cherednichenko, G., Ward, C. W., Padilla, I. T., Cabrales, E., Lopez, J. R., Eltit, J. M., Allen, P. D. and Pessah, I. N., (2010). Green tea catechins are potent sensitizers of ryanodine receptor type 1 (RyR1). Biochem Pharmacol 80(4): 512-521. Fisher, R., Salanova, V., Witt, T., Worth, R., Henry, T., Gross, R., Oommen, K., Osorio, I., Nazzaro, J., Labar, D., Kaplitt, M., Sperling, M., Sandok, E., Neal, J., Handforth, A., Stern, J., DeSalles, A., Chung, S., Shetter, A., Bergen, D., Bakay, R., Henderson, J., French, J., Baltuch, G., Rosenfeld, W., Youkilis, A., Marks, W., Garcia, P., Barbaro, N., Fountain, N., Bazil, C., Goodman, R., McKhann, G., Babu Krishnamurthy, K., Papavassiliou, S., Epstein, C., Pollard, J., Tonder, L., Grebin, J., Coffey, R. and Graves, N., (2010). Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 51(5): 899-908. Fisher, R. S., (2017). An overview of the 2017 ILAE operational classification of seizure types. Epilepsy Behav 70(Pt A): 271-273. Fotia, A. B., Ekberg, J., Adams, D. J., Cook, D. I., Poronnik, P. and Kumar, S., (2004). Regulation of neuronal voltage-gated sodium channels by the ubiquitin-protein ligases Nedd4 and Nedd4-2. J Biol Chem 279(28): 28930-28935. Gazina, E. V., Richards, K. L., Mokhtar, M. B., Thomas, E. A., Reid, C. A. and Petrou, S., (2010). Differential expression of exon 5 splice variants of sodium channel alpha subunit mRNAs in the developing mouse brain. Neuroscience 166(1): 195-200. Genton, P., (2000). When antiepileptic drugs aggravate epilepsy. Brain Dev 22(2): 75-80. Goldenberg, M. M., (2010). Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment. P t 35(7): 392-415. Goldin, A. L., (2001). Resurgence of sodium channel research. Annu Rev Physiol 63: 871-894. Goldin, A. L., (2003). Mechanisms of sodium channel inactivation. Curr Opin Neurobiol 13(3): 284-290. Gomez-Pinilla, F. and Nguyen, T. T., (2012). Natural mood foods: the actions of polyphenols against psychiatric and cognitive disorders. Nutr Neurosci 15(3): 127-133. Gong, B., Rhodes, K. J., Bekele-Arcuri, Z. and Trimmer, J. S., (1999). Type I and type II Na+ channel alpha-subunit polypeptides exhibit distinct spatial and temporal patterning, and association with auxiliary subunits in rat brain. J Comp Neurol 412(2): 342-352. Gram, L. and Schmidt, D., (1993). Innovative designs of controlled clinical trials in epilepsy. Epilepsia 34 Suppl 7: S1-6. Gross, R. A., (1992). A brief history of epilepsy and its therapy in the Western Hemisphere. Epilepsy Res 12(2): 65-74. Guerrini, R., Belmonte, A. and Genton, P., (1998). Antiepileptic drug-induced worsening of seizures in children. Epilepsia 39 Suppl 3: S2-10. Guy, H. R. and Seetharamulu, P., (1986). Molecular model of the action potential sodium channel. Proc Natl Acad Sci U S A 83(2): 508-512. Harkin, L. A., McMahon, J. M., Iona, X., Dibbens, L., Pelekanos, J. T., Zuberi, S. M., Sadleir, L. G., Andermann, E., Gill, D., Farrell, K., Connolly, M., Stanley, T., Harbord, M., Andermann, F., Wang, J., Batish, S. D., Jones, J. G., Seltzer, W. K., Gardner, A., Sutherland, G., Berkovic, S. F., Mulley, J. C. and Scheffer, I. E., (2007). The spectrum of SCN1A-related infantile epileptic encephalopathies. Brain 130(Pt 3): 843-852. Hartshorne, R. P. and Catterall, W. A., (1981). Purification of the saxitoxin receptor of the sodium channel from rat brain. Proc Natl Acad Sci U S A 78(7): 4620-4624. Hartshorne, R. P. and Catterall, W. A., (1984). The sodium channel from rat brain. Purification and subunit composition. J Biol Chem 259(3): 1667-1675. Hartshorne, R. P., Messner, D. J., Coppersmith, J. C. and Catterall, W. A., (1982). The saxitoxin receptor of the sodium channel from rat brain. Evidence for two nonidentical beta subunits. J Biol Chem 257(23): 13888-13891. Heinemann, S. H., Terlau, H. and Imoto, K., (1992). Molecular basis for pharmacological differences between brain and cardiac sodium channels. Pflugers Arch 422(1): 90-92. Heinzen, E. L., Yoon, W., Tate, S. K., Sen, A., Wood, N. W., Sisodiya, S. M. and Goldstein, D. B., (2007). Nova2 interacts with a cis-acting polymorphism to influence the proportions of drug-responsive splice variants of SCN1A. Am J Hum Genet 80(5): 876-883. Henley, J. M. and Wilkinson, K. A., (2013). AMPA receptor trafficking and the mechanisms underlying synaptic plasticity and cognitive aging. Dialogues Clin Neurosci 15(1): 11-27. Herzog, R. I., Liu, C., Waxman, S. G. and Cummins, T. R., (2003). Calmodulin binds to the C terminus of sodium channels Nav1.4 and Nav1.6 and differentially modulates their functional properties. J Neurosci 23(23): 8261-8270. Hille, B., (1977). Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol 69(4): 497-515. Hodgson, J. M., Woodman, R. J., Puddey, I. B., Mulder, T., Fuchs, D. and Croft, K. D., (2013). Short-term effects of polyphenol-rich black tea on blood pressure in men and women. Food Funct 4(1): 111-115. Hofmann, G., Balgooyen, L., Mattis, J., Deisseroth, K. and Buckmaster, P. S., (2016). Hilar somatostatin interneuron loss reduces dentate gyrus inhibition in a mouse model of temporal lobe epilepsy. Epilepsia 57(6): 977-983. Holbro, N., Grunditz, A. and Oertner, T. G., (2009). Differential distribution of endoplasmic reticulum controls metabotropic signaling and plasticity at hippocampal synapses. Proc Natl Acad Sci U S A 106(35): 15055-15060. Hu, G., Zhang, L., Rong, Y., Ni, X. and Sun, Y., (2014). Downstream carcinogenesis signaling pathways by green tea polyphenols: a translational perspective of chemoprevention and treatment for cancers. Curr Drug Metab 15(1): 14-22. Huang, W., Cane, M. C., Mukherjee, R., Szatmary, P., Zhang, X., Elliott, V., Ouyang, Y., Chvanov, M., Latawiec, D., Wen, L., Booth, D. M., Haynes, A. C., Petersen, O. H., Tepikin, A. V., Criddle, D. N. and Sutton, R., (2017). Caffeine protects against experimental acute pancreatitis by inhibition of inositol 1,4,5-trisphosphate receptor-mediated Ca2+ release. Gut 66(2): 301-313. Hung, C. C., Chen, C. C., Lin, C. J. and Liou, H. H., (2008). Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs. Pharmacogenet Genomics 18(5): 390-402. Hunt, R. F., Girskis, K. M., Rubenstein, J. L., Alvarez-Buylla, A. and Baraban, S. C., (2013). GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior. Nat Neurosci 16(6): 692-697. Inoue-Choi, M., Yuan, J. M., Yang, C. S., Van Den Berg, D. J., Lee, M. J., Gao, Y. T. and Yu, M. C., (2010). Genetic Association Between the COMT Genotype and Urinary Levels of Tea Polyphenols and Their Metabolites among Daily Green Tea Drinkers. Int J Mol Epidemiol Genet 1(2): 114-123. Ishii, T., Mori, T., Tanaka, T., Mizuno, D., Yamaji, R., Kumazawa, S., Nakayama, T. and Akagawa, M., (2008). Covalent modification of proteins by green tea polyphenol (-)-epigallocatechin-3-gallate through autoxidation. Free Radic Biol Med 45(10): 1384-1394. Iso, H., Date, C., Wakai, K., Fukui, M. and Tamakoshi, A., (2006). The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med 144(8): 554-562. Isom, L. L., (2001). Sodium channel beta subunits: anything but auxiliary. Neuroscientist 7(1): 42-54. Isom, L. L., De Jongh, K. S., Patton, D. E., Reber, B. F., Offord, J., Charbonneau, H., Walsh, K., Goldin, A. L. and Catterall, W. A., (1992). Primary structure and functional expression of the beta 1 subunit of the rat brain sodium channel. Science 256(5058): 839-842. Isom, L. L., Ragsdale, D. S., De Jongh, K. S., Westenbroek, R. E., Reber, B. F., Scheuer, T. and Catterall, W. A., (1995). Structure and function of the beta 2 subunit of brain sodium channels, a transmembrane glycoprotein with a CAM motif. Cell 83(3): 433-442. Jansen, F. E., Sadleir, L. G., Harkin, L. A., Vadlamudi, L., McMahon, J. M., Mulley, J. C., Scheffer, I. E. and Berkovic, S. F., (2006). Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adults. Neurology 67(12): 2224-2226. Jenkins, S. M. and Bennett, V., (2001). Ankyrin-G coordinates assembly of the spectrin-based membrane skeleton, voltage-gated sodium channels, and L1 CAMs at Purkinje neuron initial segments. J Cell Biol 155(5): 739-746. Jeong, H. S., Kim, Y. S. and Park, J. S., (2005). Modulation of neuronal activity by EGCG. Brain Res 1047(2): 267-270. Jin, J. Y., Park, S. H., Bae, J. H., Cho, H. C., Lim, J. G., Park, W. S., Han, J., Lee, J. H. and Song, D. K., (2007). Uncoupling by (--)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP. Pharmacol Res 56(3): 237-247. Johannessen Landmark, C. and Patsalos, P. N., (2010). Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert Rev Neurother 10(1): 119-140. Kaneko, Y. K., Takii, M., Kojima, Y., Yokosawa, H. and Ishikawa, T., (2015). Structure-dependent inhibitory effects of green tea catechins on insulin secretion from pancreatic beta-cells. Biol Pharm Bull 38(3): 476-481. Kaur, T., Pathak, C. M., Pandhi, P. and Khanduja, K. L., (2008). Effects of green tea extract on learning, memory, behavior and acetylcholinesterase activity in young and old male rats. Brain Cogn 67(1): 25-30. Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., Whaley, R., Glennon, R. A., Hert, J., Thomas, K. L., Edwards, D. D., Shoichet, B. K. and Roth, B. L., (2009). Predicting new molecular targets for known drugs. Nature 462(7270): 175-181. Keppel Hesselink, J. M. and Kopsky, D. J., (2017). Phenytoin: neuroprotection or neurotoxicity? Neurol Sci 38(6): 1137-1141. Khan, N., Afaq, F., Saleem, M., Ahmad, N. and Mukhtar, H., (2006). Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 66(5): 2500-2505. Khan, N. and Mukhtar, H., (2013). Tea and health: studies in humans. Curr Pharm Des 19(34): 6141-6147. Kim, E. J., Kim, D. K., Kim, S. H., Lee, K. M., Park, H. S. and Kim, S. H., (2011). Alteration of Ryanodine-receptors in Cultured Rat Aortic Smooth Muscle Cells. Korean J Physiol Pharmacol 15(6): 431-436. Kim, H., Hiraishi, A., Tsuchiya, K. and Sakamoto, K., (2010). (-) Epigallocatechin gallate suppresses the differentiation of 3T3-L1 preadipocytes through transcription factors FoxO1 and SREBP1c. Cytotechnology 62(3): 245-255. Kim, H. H., Lee, K. H., Lee, D., Han, Y. E., Lee, S. H., Sohn, J. W. and Ho, W. K., (2015). Costimulation of AMPA and metabotropic glutamate receptors underlies phospholipase C activation by glutamate in hippocampus. J Neurosci 35(16): 6401-6412. Kim, T. H., Lim, J. M., Kim, S. S., Kim, J., Park, M. and Song, J. H., (2009). Effects of (-) epigallocatechin-3-gallate on Na+ currents in rat dorsal root ganglion neurons. Eur J Pharmacol 604(1-3): 20-26. Kohri, T., Matsumoto, N., Yamakawa, M., Suzuki, M., Nanjo, F., Hara, Y. and Oku, N., (2001). Metabolic fate of (-)-[4-(3)H]epigallocatechin gallate in rats after oral administration. J Agric Food Chem 49(8): 4102-4112. Kontis, K. J., Rounaghi, A. and Goldin, A. L., (1997). Sodium channel activation gating is affected by substitutions of voltage sensor positive charges in all four domains. J Gen Physiol 110(4): 391-401. Korber, C. and Kuner, T., (2016). Molecular Machines Regulating the Release Probability of Synaptic Vesicles at the Active Zone. Front Synaptic Neurosci 8: 5. Kruger, L. C. and Isom, L. L., (2016). Voltage-Gated Na+ Channels: Not Just for Conduction. Cold Spring Harb Perspect Biol 8(6). Kullmann, D. M., (2010). Neurological channelopathies. Annu Rev Neurosci 33: 151-172. Kuo, C. C., (1998). A common anticonvulsant binding site for phenytoin, carbamazepine, and lamotrigine in neuronal Na+ channels. Mol Pharmacol 54(4): 712-721. Kuo, C. C. and Bean, B. P., (1994). Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons. Mol Pharmacol 46(4): 716-725. Kuo, C. C., Chen, R. S., Lu, L. and Chen, R. C., (1997). Carbamazepine inhibition of neuronal Na+ currents: quantitative distinction from phenytoin and possible therapeutic implications. Mol Pharmacol 51(6): 1077-1083. Kuo, C. C. and Lu, L., (1997). Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurones. Br J Pharmacol 121(6): 1231-1238. Kurahashi, N., Sasazuki, S., Iwasaki, M., Inoue, M. and Tsugane, S., (2008). Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol 167(1): 71-77. Kuriyama, S., Shimazu, T., Ohmori, K., Kikuchi, N., Nakaya, N., Nishino, Y., Tsubono, Y. and Tsuji, I., (2006). Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. Jama 296(10): 1255-1265. Lambert, J. D., Hong, J., Kim, D. H., Mishin, V. M. and Yang, C. S., (2004). Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice. J Nutr 134(8): 1948-1952. LaRoche, S. M., (2007). A new look at the second-generation antiepileptic drugs: a decade of experience. Neurologist 13(3): 133-139. Lason, W., Chlebicka, M. and Rejdak, K., (2013). Research advances in basic mechanisms of seizures and antiepileptic drug action. Pharmacol Rep 65(4): 787-801. Lee, C. Y., Lee, M. L., Shih, C. C. and Liou, H. H., (2011). Carisbamate (RWJ-333369) inhibits glutamate transmission in the granule cell of the dentate gyrus. Neuropharmacology 61(8): 1239-1247. Lee, J. H., Song, D. K., Jung, C. H., Shin, D. H., Park, J., Kwon, T. K., Jang, B. C., Mun, K. C., Kim, S. P., Suh, S. I. and Bae, J. H., (2004). (-)-Epigallocatechin gallate attenuates glutamate-induced cytotoxicity via intracellular Ca modulation in PC12 cells. Clin Exp Pharmacol Physiol 31(8): 530-536. Lee, M. J., Maliakal, P., Chen, L., Meng, X., Bondoc, F. Y., Prabhu, S., Lambert, G., Mohr, S. and Yang, C. S., (2002). Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 11(10 Pt 1): 1025-1032. Li, Y. X., Zhang, Y., Lester, H. A., Schuman, E. M. and Davidson, N., (1998). Enhancement of neurotransmitter release induced by brain-derived neurotrophic factor in cultured hippocampal neurons. J Neurosci 18(24): 10231-10240. Lipkind, G. M. and Fozzard, H. A., (2010). Molecular model of anticonvulsant drug binding to the voltage-gated sodium channel inner pore. Mol Pharmacol 78(4): 631-638. Liu, D., Perkins, J. T. and Hennig, B., (2016). EGCG prevents PCB-126-induced endothelial cell inflammation via epigenetic modifications of NF-kappaB target genes in human endothelial cells. J Nutr Biochem 28: 164-170. Lu, H., Meng, X., Li, C., Sang, S., Patten, C., Sheng, S., Hong, J., Bai, N., Winnik, B., Ho, C. T. and Yang, C. S., (2003). Glucuronides of tea catechins: enzymology of biosynthesis and biological activities. Drug Metab Dispos 31(4): 452-461. Mantegazza, M., Curia, G., Biagini, G., Ragsdale, D. S. and Avoli, M., (2010). Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders. Lancet Neurol 9(4): 413-424. Martin, M. S., Dutt, K., Papale, L. A., Dube, C. M., Dutton, S. B., de Haan, G., Shankar, A., Tufik, S., Meisler, M. H., Baram, T. Z., Goldin, A. L. and Escayg, A., (2010). Altered function of the SCN1A voltage-gated sodium channel leads to gamma-aminobutyric acid-ergic (GABAergic) interneuron abnormalities. J Biol Chem 285(13): 9823-9834. Masuda, M., Suzui, M. and Weinstein, I. B., (2001). Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 7(12): 4220-4229. McLean, M. J. and Macdonald, R. L., (1983). Multiple actions of phenytoin on mouse spinal cord neurons in cell culture. J Pharmacol Exp Ther 227(3): 779-789. Messner, D. J. and Catterall, W. A., (1985). The sodium channel from rat brain. Separation and characterization of subunits. J Biol Chem 260(19): 10597-10604. Morgan, K., Stevens, E. B., Shah, B., Cox, P. J., Dixon, A. K., Lee, K., Pinnock, R. D., Hughes, J., Richardson, P. J., Mizuguchi, K. and Jackson, A. P., (2000). beta 3: an additional auxiliary subunit of the voltage-sensitive sodium channel that modulates channel gating with distinct kinetics. Proc Natl Acad Sci U S A 97(5): 2308-2313. Motoike, H. K., Liu, H., Glaaser, I. W., Yang, A. S., Tateyama, M. and Kass, R. S., (2004). The Na+ channel inactivation gate is a molecular complex: a novel role of the COOH-terminal domain. J Gen Physiol 123(2): 155-165. Mu, Y., Otsuka, T., Horton, A. C., Scott, D. B. and Ehlers, M. D., (2003). Activity-dependent mRNA splicing controls ER export and synaptic delivery of NMDA receptors. Neuron 40(3): 581-594. Mulley, J. C., Scheffer, I. E., Petrou, S., Dibbens, L. M., Berkovic, S. F. and Harkin, L. A., (2005). SCN1A mutations and epilepsy. Hum Mutat 25(6): 535-542. Naumovski, N., Blades, B. L. and Roach, P. D., (2015). Food Inhibits the Oral Bioavailability of the Major Green Tea Antioxidant Epigallocatechin Gallate in Humans. Antioxidants (Basel) 4(2): 373-393. Nelson, M., Yang, M., Dowle, A. A., Thomas, J. R. and Brackenbury, W. J., (2015). The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis. Mol Cancer 14: 13. Noda, M., Suzuki, H., Numa, S. and Stuhmer, W., (1989). A single point mutation confers tetrodotoxin and saxitoxin insensitivity on the sodium channel II. FEBS Lett 259(1): 213-216. O'Brien, J. E. and Meisler, M. H., (2013). Sodium channel SCN8A (Nav1.6): properties and de novo mutations in epileptic encephalopathy and intellectual disability. Front Genet 4: 213. O'Connor, E. R., Sontheimer, H., Spencer, D. D. and de Lanerolle, N. C., (1998). Astrocytes from human hippocampal epileptogenic foci exhibit action potential-like responses. Epilepsia 39(4): 347-354. Ogiwara, I., Miyamoto, H., Morita, N., Atapour, N., Mazaki, E., Inoue, I., Takeuchi, T., Itohara, S., Yanagawa, Y., Obata, K., Furuichi, T., Hensch, T. K. and Yamakawa, K., (2007). Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J Neurosci 27(22): 5903-5914. Pal, D. K., Pong, A. W. and Chung, W. K., (2010). Genetic evaluation and counseling for epilepsy. Nat Rev Neurol 6(8): 445-453. Pan, C. Y., Kao, Y. H. and Fox, A. P., (2002). Enhancement of inward Ca2+ currents in bovine chromaffin cells by green tea polyphenol extracts. Neurochem Int 40(2): 131-137. Park, H. J., Lee, J. Y., Chung, M. Y., Park, Y. K., Bower, A. M., Koo, S. I., Giardina, C. and Bruno, R. S., (2012). Green tea extract suppresses NFkappaB activation and inflammatory responses in diet-induced obese rats with nonalcoholic steatohepatitis. J Nutr 142(1): 57-63. Patejdl, R., Leroux, A. C. and Noack, T., (2015). Phenytoin inhibits contractions of rat gastrointestinal and portal vein smooth muscle by inhibiting calcium entry. Neurogastroenterol Motil 27(10): 1453-1465. Payandeh, J., Scheuer, T., Zheng, N. and Catterall, W. A., (2011). The crystal structure of a voltage-gated sodium channel. Nature 475(7356): 353-358. Peairs, A., Dai, R., Gan, L., Shimp, S., Rylander, M. N., Li, L. and Reilly, C. M., (2010). Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells. Cell Mol Immunol 7(2): 123-132. Peng, Z., Zhang, N., Wei, W., Huang, C. S., Cetina, Y., Otis, T. S. and Houser, C. R., (2013). A reorganized GABAergic circuit in a model of epilepsy: evidence from optogenetic labeling and stimulation of somatostatin interneurons. J Neurosci 33(36): 14392-14405. Ptak, K., Zummo, G. G., Alheid, G. F., Tkatch, T., Surmeier, D. J. and McCrimmon, D. R., (2005). Sodium currents in medullary neurons isolated from the pre-Botzinger complex region. J Neurosci 25(21): 5159-5170. Pusch, M., Noda, M., Stuhmer, W., Numa, S. and Conti, F., (1991). Single point mutations of the sodium channel drastically reduce the pore permeability without preventing its gating. Eur Biophys J 20(3): 127-133. Qiao, J., Kong, X., Kong, A. and Han, M., (2014). Pharmacokinetics and biotransformation of tea polyphenols. Curr Drug Metab 15(1): 30-36. Qu, Y., Curtis, R., Lawson, D., Gilbride, K., Ge, P., DiStefano, P. S., Silos-Santiago, I., Catterall, W. A. and Scheuer, T., (2001). Differential modulation of sodium channel gating and persistent sodium currents by the beta1, beta2, and beta3 subunits. Mol Cell Neurosci 18(5): 570-580. Ragsdale, D. S., (2008). How do mutant Nav1.1 sodium channels cause epilepsy? Brain Res Rev 58(1): 149-159. Ragsdale, D. S. and Avoli, M., (1998). Sodium channels as molecular targets for antiepileptic drugs. Brain Res Brain Res Rev 26(1): 16-28. Ragsdale, D. S., Scheuer, T. and Catterall, W. A., (1991). Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs. Mol Pharmacol 40(5): 756-765. Raj, B. and Blencowe, B. J., (2015). Alternative Splicing in the Mammalian Nervous System: Recent Insights into Mechanisms and Functional Roles. Neuron 87(1): 14-27. Rakhade, S. N. and Jensen, F. E., (2009). Epileptogenesis in the immature brain: emerging mechanisms. Nat Rev Neurol 5(7): 380-391. Reichling, D. B. and MacDermott, A. B., (1993). Brief calcium transients evoked by glutamate receptor agonists in rat dorsal horn neurons: fast kinetics and mechanisms. J Physiol 469: 67-88. Remy, S. and Beck, H., (2006). Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Brain 129(Pt 1): 18-35. Rezai-Zadeh, K., Shytle, D., Sun, N., Mori, T., Hou, H., Jeanniton, D., Ehrhart, J., Townsend, K., Zeng, J., Morgan, D., Hardy, J., Town, T. and Tan, J., (2005). Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 25(38): 8807-8814. Rossi, A. R., Angelo, M. F., Villarreal, A., Lukin, J. and Ramos, A. J., (2013). Gabapentin administration reduces reactive gliosis and neurodegeneration after pilocarpine-induced status epilepticus. PLoS One 8(11): e78516. Sands, Z., Gro | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/69972 | - |
dc.description.abstract | 癲癇是一種神經過度興奮性症狀,而苯妥英鈉是一種常見的抗癲癇藥物,主要的作用是抑制鈉離子通道的活性。然而過去研究,對於苯妥英鈉 (phenytoin) 如何透過神經突觸的傳遞,來調節緩解癲癇症狀的機制仍不甚了解。在此研究中,使用初級培養的大鼠胚胎神經細胞進行實驗,發現苯妥英鈉以濃度依賴性的方式,抑制內流鈉離子的電流,其半抑制濃度(IC50)約為16.8 M。在處理苯妥英鈉濃度100 M時,對鈉電流的抑制作用與給予的刺激頻率有使用依賴性的正比關係;且顯著降低神經細胞的動作電位頻率。利用雷射光裂解技術於局部釋放興奮性神經傳導物質--麩胺酸 (Glutamate),並測量受刺激的目標神經及其相鄰連接的神經細胞胞內鈣離子濃度的變化,以探討神經傳導的變化。在給予強度光裂解刺激下,苯妥英鈉能顯著抑制目標神經和鄰近細胞被誘發的細胞內鈣離子濃度的上升,但此明顯的抑制作用在給予中度光裂解刺激時,則會被減弱。進一步以第一型γ-氨基丁酸 (GABA)受體拮抗劑印防己毒素 (picrotoxin) 處理神經細胞,以增加自發興奮性突觸後電流 (sEPSC) 的發生。而苯妥英鈉對> 100 pA的自發興奮性突觸後電流,有較為顯著的抑制效果,但對< 100 pA的突觸後電流,則僅有輕微影響。在人類胚胎腎細胞 (HEK293) 中,表現第一型電壓調控依賴性鈉離子通道 (Nav1.1),苯妥英鈉能抑制通道電流,並延長了鈉離子通道從失活態恢復到可再開啟的時間,但不影響通道激活和失活的特性。這些結果顯示,苯妥英鈉藉由延長鈉離子通道恢復所需時間,限制了鈉離子通道的可用性,以降低神經傳遞的效率,以舒緩因癲癇發作造成神經過度興奮的高頻神經活動。
綠茶萃取物對於人體具有許多健康的益處,其中表兒茶素沒食子酸鹽 ((-)-Epicatechin-3-gallate,ECG) 及表沒食子兒茶素沒食子酸酯 (Epigallocatechin-3-gallate,EGCG) 是綠茶多酚的主要化合物;一般多針對其抗氧化能力、對神經退化性疾病和癌症的相關保護作用進行討論,但是對於抗焦慮及神經鎮靜作用的機制仍不甚了解。在本研究中,前處理一小時綠茶多酚的初級培養大鼠胚胎神經細胞,其鈉離子內流電流、麩胺酸受體電流及動作電位頻率都會受到抑制。分別刺激離子型或代謝型麩胺酸亞受體,所誘發的細胞內鈣離子變化,也都會受到綠茶多酚前處理的抑制,因此對整體的神經活性產生鎮靜的作用。 | zh_TW |
dc.description.abstract | Phenytoin is an effective antiepileptic drug (AED) that inhibits Na+ channel activities; however, how phenytoin modulates synaptic transmission to soothe epileptic symptoms is not clear. To characterize the effects of phenytoin on neurotransmission, we used cultured embryonic cortical neurons to study the electrophysical properties before and after phenytoin treatment. Phenytoin inhibited the inward Na+ current in a dose-dependent manner with an IC50 of 16.8 μM, and at 100 μM, the inhibitory effect of phenytoin on the Na+ current was proportional to the stimulation frequency applied. In cultured neurons, phenytoin significantly decreased the action potential (AP) firing rate. To study the effect of phenytoin in neurotransmission, we measured the intracellular calcium concentration ([Ca2+]i) responses from stimulated target neurons and their neighboring neurons. Phenytoin significantly suppressed the [Ca2+]i responses evoked by strong stimulations in the target and neighboring neurons, and exerted a decreased inhibitory effect under moderate stimulation. Picrotoxin, a GABAA receptor antagonist, enhanced the recorded spontaneous excitatory postsynaptic current (sEPSC) activities. After picrotoxin-induced enhancement, phenytoin had a more pronounced effect on the suppression of the hyper-exciting sEPSC (> 100 pA), but it only mildly inhibited the averaged EPSC. Furthermore, phenytoin inhibited the Nav1.1 currents expressed in HEK293T cells and prolonged the recovery time from inactivation without affecting the voltage-dependent activation and inactivation properties. Our results demonstrate that phenytoin suppresses the efficacy of neurotransmission especially for the high-frequency stimulation by lengthening the Na+ channel recovery time from inactivation which limits Na+ channel availability and can potentially alleviate epileptic activity.
The (−)-epicatechin gallate (ECG) and epigallocatechin-3-gallate (EGCG) are the major compounds of green tea polyphenols. It has been extensively studied for their neuroprotective effects on neurodegenerative diseases and cancer, but the effects on neurotransmission are unclear. In this study, we used calcium imaging and patch-clamp techniques to determine the effects of ECG and EGCG on regulating the neurotransmission among cultured embryonic cortical neurons. The results indicated that ECG and EGCG at 10 μM inhibit the voltage-gated Na+ currents, reduce the N-methyl-D-aspartate (NMDA)-evoked currents, and furthermore decrease the AP firing rate. By monitoring the [Ca2+]i, both ECG and EGCG inhibited the [Ca2+]i responses via activating the α-amino-3-hydroxy-5-methyl-4-isoxazole-proprionate (AMPA) receptors or the metabotropic glutamate receptors. Overall, ECG and EGCG suppress the neurological activities and synaptic transmission resulting in sedation. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T03:36:44Z (GMT). No. of bitstreams: 1 ntu-106-D98b41012-1.pdf: 3312701 bytes, checksum: 531e122ebef696029dfb1ec2d3c1f441 (MD5) Previous issue date: 2017 | en |
dc.description.tableofcontents | 摘要 i
ABSTRACT iii CONTENTS v INTRODUCTION 1 1.The Glutamate Receptors 1 2.The VGSCs 3 3.Structural Elements Underlying Channel Gating 6 4.Inactivation of the VGSCs 7 5.Epilepsy Syndromes 9 6.SCN1A (Nav1.1) and Epilepsy 12 7.Alternative Splicing in SCN1A Genes during Epilepsy 13 8.AEDs and Phenytoin 15 9.Green Tea Catechins 17 AIMS 21 MATERIALS and METHODS 22 1.Chemicals 22 2.Cultured Cortical Neurons 22 3.HEK 293 Cell Culture and Transection 23 4.Electrophysiology 24 5.Flash-Photolysis and Synaptic Transmission 27 6.Data Analysis 28 RESULTS 29 1.Phenytoin inhibits Na+ currents 29 2.Phenytoin diminishes repetitively evoked Na+ currents 30 3.Phenytoin inhibits AP firing 31 4.Phenytoin inhibits synaptic transmission 32 5.Phenytoin slightly, but significantly, inhibits mild stimulation evoked [Ca2+]i responses 34 6.Phenytoin suppresses the picrotoxin-enhanced EPSCs without affecting glutamate receptor activation 35 7.Differential effects of phenytoin on SCN1A isoforms 38 8.Phenytoin has no effect on Nav1.4 39 9.Transient ECG/EGCG treatment has on effect on neuronal Na+ currents 40 10.ECG/EGCG pretreatment inhibits the voltage-gated Na+ currents 40 11.ECG/EGCG attenuates the AP firing frequency 41 12.ECG/EGCG inhibits glutamate-induced [Ca2+]i elevation 42 13.ECG/EGCG inhibits AMPA/DHPG-induced [Ca2+]i elevation 43 14.ECG/EGCG attenuates the evoked-EPSC 44 DISCUSSION 46 CONCLUSION 58 REFERENCES 59 TABLES 96 Table 1.Characteristics of sEPSCs in neurons treated with phenytoin 96 Table 2.Characteristics of the spontaneous EPSCs 97 Table 3.Effects of phenytoin on the biophysical properties of SCN1A isoforms 98 Table 4.Effects of EGCG and ECG on the biophysical properties 99 FIGURES 100 Fig. 1.Current density in cultured cortical neurons treat with mock solution 101 Fig. 2.Phenytoin inhibits Na+ currents in cultured cortical neurons 103 Fig. 3.Phenytoin inactivates Na+ currents during repetitive depolarizations 105 Fig. 4.Phenytoin decreases the AP firing frequency 107 Fig. 5.Phenytoin inhibits evoked neurotransmission in cultured cortical neurons 109 Fig. 6.Phenytoin slightly inhibits neurotransmission evoked by mild stimulation 111 Fig. 7.Phenytoin inhibits AP firing without affecting glutamate receptor activation 113 Fig. 8.Phenytoin inhibits the picrotoxin-enhanced synaptic activity 115 Fig. 9.Phenytoin inhibits evoked EPSCs in cultured cortical neurons 117 Fig. 10.SCN1A alternatively spliced isoforms have different recovery times 119 Fig. 11.Effects of phenytoin on Nav1.4 121 Fig. 12.Transient ECG/EGCG treatment has no effect on Na+ currents 123 Fig. 13.ECG/EGCG pretreatment inhibits the voltage-gated Na+ currents 125 Fig. 14.ECG/EGCG attenuates the AP firing frequency 127 Fig. 15.ECG/EGCG inhibits glutamate-induced [Ca2+]i elevation 129 Fig. 16.ECG/EGCG inhibits AMPA/DHPG-induced [Ca2+]i elevation 131 Fig. 17.ECG/EGCG attenuates the evoked-EPSC in the cortical neurons 133 APPENDIX 134 | |
dc.language.iso | en | |
dc.title | 苯妥英鈉和多酚對神經傳遞的影響 | zh_TW |
dc.title | Effects of Phenytoin and Polyphenols on Neurotransmission | en |
dc.type | Thesis | |
dc.date.schoolyear | 106-1 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 陳志成(Chih-Cheng Chen),劉宏輝(Horng-Huei Liou),李銘仁(Ming-Jen Lee),李怡萱(Yi-Hsuan Lee),楊雅晴(Ya-Chin Yang) | |
dc.subject.keyword | 神經突觸傳遞,興奮性突觸後電流,苯妥英鈉,印防己毒素,表兒茶素沒食子酸鹽,表沒食子兒茶素沒食子酸酯,電壓調控依賴性鈉離子通道, | zh_TW |
dc.subject.keyword | neurotransmission,excitatory postsynaptic current,phenytoin,picrotoxin,(?)-epicatechin gallate,epigallocatechin-3-gallate,voltage-gated Na+ channel, | en |
dc.relation.page | 135 | |
dc.identifier.doi | 10.6342/NTU201800469 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2018-02-12 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 生命科學系 | zh_TW |
顯示於系所單位: | 生命科學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-106-1.pdf 目前未授權公開取用 | 3.24 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。